Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.

Lee YY, Wei YC, Tian YF, Sun DP, Sheu MJ, Yang CC, Lin LC, Lin CY, Hsing CH, Li WS, Li CF, Hsieh PL, Lin CY.

J Cancer. 2017 May 12;8(8):1330-1337. doi: 10.7150/jca.18274. eCollection 2017.

2.

Functional variants of the 5-methyltetrahydrofolate-homocysteine methyltransferase gene significantly increase susceptibility to prostate cancer: Results from an ethnic Han Chinese population.

Qu YY, Zhou SX, Zhang X, Zhao R, Gu CY, Chang K, Yang XQ, Gan HL, Dai B, Zhang HL, Shi GH, Zhu Y, Ye DW, Zhao JY.

Sci Rep. 2016 Nov 3;6:36264. doi: 10.1038/srep36264.

3.
4.

Important molecular genetic markers of colorectal cancer.

Kudryavtseva AV, Lipatova AV, Zaretsky AR, Moskalev AA, Fedorova MS, Rasskazova AS, Shibukhova GA, Snezhkina AV, Kaprin AD, Alekseev BY, Dmitriev AA, Krasnov GS.

Oncotarget. 2016 Aug 16;7(33):53959-53983. doi: 10.18632/oncotarget.9796. Review.

5.

Assessing the potential value of long interspersed element-1 hypomethylation in colorectal cancer: evidence from retrospective studies.

Tang JT, Wang ZH, Fang JY.

Onco Targets Ther. 2015 Nov 5;8:3265-76. doi: 10.2147/OTT.S91941. eCollection 2015.

6.

Associations between genetic variation in one-carbon metabolism and LINE-1 DNA methylation in histologically normal breast tissues.

Llanos AA, Marian C, Brasky TM, Dumitrescu RG, Liu Z, Mason JB, Makambi KH, Spear SL, Kallakury BV, Freudenheim JL, Shields PG.

Epigenetics. 2015;10(8):727-35. doi: 10.1080/15592294.2015.1062205. Erratum in: Epigenetics. 2015;10(11):1091.

7.

Single nucleotide polymorphisms of one-carbon metabolism and cancers of the esophagus, stomach, and liver in a Chinese population.

Chang SC, Chang PY, Butler B, Goldstein BY, Mu L, Cai L, You NC, Baecker A, Yu SZ, Heber D, Lu QY, Li L, Greenland S, Zhang ZF.

PLoS One. 2014 Oct 22;9(10):e109235. doi: 10.1371/journal.pone.0109235. eCollection 2014.

8.

Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression.

Lochhead P, Chan AT, Nishihara R, Fuchs CS, Beck AH, Giovannucci E, Ogino S.

Mod Pathol. 2015 Jan;28(1):14-29. doi: 10.1038/modpathol.2014.81. Epub 2014 Jun 13. Review.

9.

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.

Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E.

Mod Pathol. 2013 Apr;26(4):465-84. doi: 10.1038/modpathol.2012.214. Epub 2013 Jan 11. Review.

10.

Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level.

Ogino S, Nishihara R, Lochhead P, Imamura Y, Kuchiba A, Morikawa T, Yamauchi M, Liao X, Qian ZR, Sun R, Sato K, Kirkner GJ, Wang M, Spiegelman D, Meyerhardt JA, Schernhammer ES, Chan AT, Giovannucci E, Fuchs CS.

J Natl Cancer Inst. 2013 Jan 16;105(2):130-40. doi: 10.1093/jnci/djs482. Epub 2012 Nov 21.

11.

Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science.

Ogino S, King EE, Beck AH, Sherman ME, Milner DA, Giovannucci E.

Am J Epidemiol. 2012 Oct 15;176(8):659-67. doi: 10.1093/aje/kws226. Epub 2012 Aug 30.

12.

Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications.

Kitkumthorn N, Mutirangura A.

Clin Epigenetics. 2011 Aug;2(2):315-30. doi: 10.1007/s13148-011-0032-8. Epub 2011 Apr 10.

13.

Sex-specific association of sequence variants in CBS and MTRR with risk for promoter hypermethylation in the lung epithelium of smokers.

Flores KG, Stidley CA, Mackey AJ, Picchi MA, Stabler SP, Siegfried JM, Byers T, Berwick M, Belinsky SA, Leng S.

Carcinogenesis. 2012 Aug;33(8):1542-7. doi: 10.1093/carcin/bgs194. Epub 2012 Jun 4.

14.

The causal roles of vitamin B(12) and transcobalamin in prostate cancer: can Mendelian randomization analysis provide definitive answers?

Collin SM, Metcalfe C, Palmer TM, Refsum H, Lewis SJ, Smith GD, Cox A, Davis M, Marsden G, Johnston C, Lane JA, Donovan JL, Neal DE, Hamdy FC, Smith AD, Martin RM.

Int J Mol Epidemiol Genet. 2011;2(4):316-27. Epub 2011 Nov 28.

15.

Epigenetics and colorectal cancer.

Lao VV, Grady WM.

Nat Rev Gastroenterol Hepatol. 2011 Oct 18;8(12):686-700. doi: 10.1038/nrgastro.2011.173. Review.

16.

B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP).

Schernhammer ES, Giovannucci E, Baba Y, Fuchs CS, Ogino S.

PLoS One. 2011;6(6):e21102. doi: 10.1371/journal.pone.0021102. Epub 2011 Jun 27.

17.

Dihydrofolate reductase gene variations in susceptibility to disease and treatment outcomes.

Askari BS, Krajinovic M.

Curr Genomics. 2010 Dec;11(8):578-83. doi: 10.2174/138920210793360925.

18.

CpG island methylation in colorectal cancer: past, present and future.

Curtin K, Slattery ML, Samowitz WS.

Patholog Res Int. 2011 Apr 12;2011:902674. doi: 10.4061/2011/902674.

19.

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Ogino S, Chan AT, Fuchs CS, Giovannucci E.

Gut. 2011 Mar;60(3):397-411. doi: 10.1136/gut.2010.217182. Epub 2010 Oct 29. Review.

20.

Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators: diet-gene interactions and promoter CpG island hypermethylation in colorectal cancer.

de Vogel S, Wouters KA, Gottschalk RW, van Schooten FJ, de Goeij AF, de Bruïne AP, Goldbohm RA, van den Brandt PA, van Engeland M, Weijenberg MP.

Cancer Causes Control. 2011 Jan;22(1):1-12. doi: 10.1007/s10552-010-9659-6. Epub 2010 Oct 20.

Supplemental Content

Support Center